SCHEMBL26051110

SCHEMBL26051110

CC(C)c1cnc(-c2ncccc2F)s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 6/20 0.35
▸ CDK2 P24941 6/20 0.35
▸ CDK5 Q00535 6/20 0.35
▸ CYP2D6 P10635 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ GABRG2 P18507 4/20 0.33
▸ GABRB3 P28472 4/20 0.33
▸ GABRA5 P31644 4/20 0.33
▸ GABRA3 P34903 4/20 0.33
▸ GABRA1 P14867 3/20 0.33
▸ CCNT1 O60563 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCNB1 P14635 1/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ CDK7 P50613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26066975 0.79 ADORA2A (0.41) CDK2GABRG2GABRB3GABRA5GABRA3
SCHEMBL23367933 0.79 ALDH1A1 (0.42) CCNE1CDK2CDK5CCNT1ALDH1A1
SCHEMBL26066988 0.72 ALDH1A1 (0.54) CCNE1CDK2CDK5GABRA1ALDH1A1
SCHEMBL1315744 0.72 CYP2A6 (0.41) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL2818608 0.71 HPGDS (0.54) CYP2D6ALDH1A1SMN1; SMN2
SCHEMBL2819462 0.69 ALDH1A1 (0.47) CCNE1CDK2CDK5CCNT1ALDH1A1
SCHEMBL23367916 0.69 KDM4E (0.46) SMN1; SMN2
SCHEMBL15624391 0.69 TDP1 (0.44) CYP2D6GABRG2GABRB3GABRA5GABRA3
SCHEMBL26051056 0.68 CCNE1 (0.34) CCNE1CDK2CDK5CCNT1ALDH1A1
SCHEMBL30482478 0.67 BACE1 (0.41) GABRG2GABRB3GABRA5GABRA3GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164234-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. (US) 2023-08-31 — — WO disclosed
WO-2023164237-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. (US) 2023-08-31 — — WO disclosed
Send feedback